Inventing the future of male contraception.
Contraline is a biotechnology company inventing the future of male contraception. The company is developing two products: ADAM™, an injectable hydrogel implant designed to provide long-lasting, reversible barrier contraception for men without affecting sensation, and NES/T, a daily topical gel that suppresses sperm production reversibly. ADAM successfully completed its first-in-human clinical trial and Contraline holds an exclusive license for NES/T. Contraline's mission is to deliver highly effective, safe, and reversible male contraceptives that fit seamlessly into people's lives.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2025
Nov 2022
Oct 2021
Jun 2016
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
